Nikolaos Chalkias

Sloane Robinson LLP is the alternative investment management subsidiary of Sloane Robinson Investment Services Ltd. in Great Britain. The firm was founded by Hugh Sloane and George Robinson in 1993 as Sloane Robinson Investment Management Ltd. They changed their name to Sloane Robinson Investment Partners LLP in 2004. Headquartered in London, Sloane Robinson manages assets with an absolute return focus on behalf of professional investors throughout the world.

Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.

Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom.

John Swire & Sons (H.K.) Ltd. is an investment holding company. The company was founded on October 30, 1947 and is headquartered in Hong Kong.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Commerce Decisions Ltd. develops enterprise software. It offers software and services to support the procurement and post contract review processes for both buyers and suppliers. The company was founded by Steven Dey and John Thompson and is headquartered in Oxfordshire, the United Kingdom.

Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom.

Microvisk Ltd. engages in the manufacture and development of micro-viscometer based on micro electro mechanical sensors technology for medical field. The firm's products include CoagMax, CoagLite, CoagManager and SmartStrip. It develops technology for the detection and analysis of a fluid's properties using a cantilever-based micro-viscometer. The company was founded by Vladislav Djakov, Paul Morgan Vernon and Jeremy Burford Peckham in 2004 and is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

Oxford Photovoltaics Ltd. develops and commercialize perovskite-based technology. Its technology can be coated on architectural glass to allow large buildings to generate a significant proportion of their electricity demand, effectively turning them into vertical solar farms. The firm investors include MTI partners, Longwall Venture Partners LLP, Parkwalk, University of Oxford (OSEM). The company was founded by Kevin Arthur and Henry Snaith in December 2010 and is headquartered in Kidlington, the United Kingdom.

The National Cancer Research Institute (NCRI) is an organization that focuses on advancing cancer research with the input of cancer patients and carers. The non-profit company is based in London, UK. The British company collects research funding data to understand how money is distributed across various areas of research and identify any gaps. NCRI is creating a research-ready workforce, strengthening the retention of early career researchers and facilitating the early interaction of clinical and preclinical researchers. The company aims to deliver better outcomes for those affected by cancer by identifying gaps in research and addressing them.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom.

Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.

Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom.

The Maggie Keswick Jencks Cancer Caring Centres Trust provides free practical, emotional, and social support services to people with cancer. The non-profit company is based in Edinburgh, UK. The British company was founded in 1996 by Maggie Keswick Jencks and Charles Jencks. Dame Laura Lee has been the CEO of the company since 1998.

Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London.

Bodle Technologies Ltd. provides advanced optoelectronic solutions for revolutionary displays and smart windows. The company was founded by David Fyfe, Harish Bhaskaran, and Peiman Hosseini in 2015 and is headquartered in Begbroke, the United Kingdom.

Betaglue Technologies SpA is a holding company, which engages in the provision of medical technology and oncology research services. The company was founded by Francesco Izzo and is headquartered in Naples, Italy.

Cripps Barn Group Ltd. operates a wedding venue.

Oxford Transplant Foundation is a non-profit organization based in Abingdon, UK. The foundation aims to advance the science and practice of transplantation by building and equipping clinical and research facilities, providing ongoing funding for these facilities, funding education, training, and research posts connected with the facilities, providing information for patients, donors, relatives, carers, and others with an interest in transplantation, and raising funds for the sole benefit of the Oxford Transplant Centre. The foundation also offers travel grants, patient information, and a patient panel. The Oxford Transplant Centre is staffed by consultants, transplant nurse specialists, and researchers who work on new technology and pump-priming grants. The foundation's mission is to further the science and practice of transplantation.

Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom.

Founded in 2019, Summit (Oxford) Ltd. is a subsidiary of Summit Therapeutics, Inc. that engages in the discovery and development of novel drugs. The company is based in Abingdon, UK.

OrthoSon Ltd. engages in the development of novel medical device for the treatment of chronic low back pain. The company was founded by Constantin Coussios and is headquartered in Oxford, the United Kingdom.